Amphastar Pharmaceuticals, Inc.

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
13
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1124-2017Class IIKetorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, AmphastAugust 15, 2017